In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish

• Published in: Frontiers in pharmacology Vol. 15; p. 1363545
• Main Authors: Bustad, Ethan, Mudrock, Emma, Nilles, Elizabeth M, Mcquate, Andrea, Bergado, Monica, Gu, Alden, Galitan, Louie, Gleason, Natalie, Ou, Henry C, Raible, David W, Hernandez, Rafael E, Ma, Shuyi
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 07.03.2024
• Subjects: aminoglycosides; drug-drug interactions; otoprotection; ototoxicity; Pharmacology; toxicity protection; zebrafish; drug-drug interactions; macrolides; ototoxicity; otoprotection; toxicity protection; aminoglycosides; zebrafish
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2024.1363545

Ototoxicity is a debilitating side effect of over 150 medications with diverse mechanisms of action, many of which could be taken concurrently to treat multiple conditions. Approaches for preclinical evaluation of drug-drug interactions that might impact ototoxicity would facilitate design of safer multi-drug regimens and mitigate unsafe polypharmacy by flagging combinations that potentially cause adverse interactions for monitoring. They may also identify protective agents that antagonize ototoxic injury. To address this need, we have developed a novel workflow that we call Parallelized Evaluation of Protection and Injury for Toxicity Assessment (PEPITA), which empowers high-throughput, semi-automated quantification of ototoxicity and otoprotection in zebrafish larvae via microscopy. We used PEPITA and confocal microscopy to characterize in vivo the consequences of drug-drug interactions on ototoxic drug uptake and cellular damage of zebrafish lateral line hair cells. By applying PEPITA to measure ototoxic drug interaction outcomes, we discovered antagonistic interactions between macrolide and aminoglycoside antibiotics that confer protection against aminoglycoside-induced damage to lateral line hair cells in zebrafish larvae. Co-administration of either azithromycin or erythromycin in zebrafish protected against damage from a broad panel of aminoglycosides, at least in part via inhibiting drug uptake into hair cells via a mechanism independent from hair cell mechanotransduction. Conversely, combining macrolides with aminoglycosides in bacterial inhibition assays does not show antagonism of antimicrobial efficacy. The proof-of-concept otoprotective antagonism suggests that combinatorial interventions can potentially be developed to protect against other forms of toxicity without hindering on-target drug efficacy.